Diagnóstico do sistema produtivo do cajueiro no Sudeste do Piauí.

Este trabalhou objetivou coletar informações preliminares sobre os sistemas de produção empregados na Microrregião Sudeste piauiense, com ênfase nos fatores fitossanitários mais limitantes e nos aspectos socieconômicos relevantes para o desenvolvimento da cultura do cajueiro.bitstream/CNPAT-2010/9018/1/Ct-083.pd

Lixa-grande: nova doença do coqueiro no Estado do Ceará.

Coqueiro - Doença - Control

Desenvolvimento inicial de pomeleiro Flame sobre diferentes porta-enxertos e espaçamento adensado no Semiárido do Ceará.

O trabalho teve como objetivo avaliar o desenvolvimento vegetativo inicial de pomeleiros "Flame" sobre diferentes porta-enxertos cítricos em condições de Semiárido Cearense

Monitoramento de doenças na cultura do cajueiro

bitstream/CNPAT/7903/1/doc47.pd

Monitoramento de doenças na cultura do cajueiro.

Este documento visa prover os profissionais engajados diretamente no processo de produção integrada de caju, de informações importantes para o monitoramento das principais doenças do cajueiro; Fenologia e operaçõe agrícola do cajueiro anão precoce no Ceará; Definições gerais para amostragem de doenças em cajueiro; Modelo de esquema de caminhamento para amostragem de doenças em um pomar de cajueiro; Antracnose; Mofo-preto; Mancha-angular; Resinose; Podridão-preta-da-haste; Oídio; Cáculo do índice de severidade e da incidência das doenças.bitstream/item/178562/1/Dc-047.pd

International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module

•We report INICC device-associated module data of 50 countries from 2010-2015.•We collected prospective data from 861,284 patients in 703 ICUs for 3,506,562 days.•DA-HAI rates and bacterial resistance were higher in the INICC ICUs than in CDC-NHSN's.•Device utilization ratio in the INICC ICUs was similar to CDC-NHSN's. Background: We report the results of International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2010-December 2015 in 703 intensive care units (ICUs) in Latin America, Europe, Eastern Mediterranean, Southeast Asia, and Western Pacific. Methods: During the 6-year study period, using Centers for Disease Control and Prevention National Healthcare Safety Network (CDC-NHSN) definitions for device-associated health care-associated infection (DA-HAI), we collected prospective data from 861,284 patients hospitalized in INICC hospital ICUs for an aggregate of 3,506,562 days. Results: Although device use in INICC ICUs was similar to that reported from CDC-NHSN ICUs, DA-HAI rates were higher in the INICC ICUs: in the INICC medical-surgical ICUs, the pooled rate of central line-associated bloodstream infection, 4.1 per 1,000 central line-days, was nearly 5-fold higher than the 0.8 per 1,000 central line-days reported from comparable US ICUs, the overall rate of ventilator-associated pneumonia was also higher, 13.1 versus 0.9 per 1,000 ventilator-days, as was the rate of catheter-associated urinary tract infection, 5.07 versus 1.7 per 1,000 catheter-days. From blood cultures samples, frequencies of resistance of Pseudomonas isolates to amikacin (29.87% vs 10%) and to imipenem (44.3% vs 26.1%), and of Klebsiella pneumoniae isolates to ceftazidime (73.2% vs 28.8%) and to imipenem (43.27% vs 12.8%) were also higher in the INICC ICUs compared with CDC-NHSN ICUs. Conclusions: Although DA-HAIs in INICC ICU patients continue to be higher than the rates reported in CDC-NSHN ICUs representing the developed world, we have observed a significant trend toward the reduction of DA-HAI rates in INICC ICUs as shown in each international report. It is INICC's main goal to continue facilitating education, training, and basic and cost-effective tools and resources, such as standardized forms and an online platform, to tackle this problem effectively and systematically